Antibiotic resistance: a view from the pharmaceutical industry.
The development of new antibiotics has been successful in significantly reducing morbidity and mortality. With increasing use there has occurred an increase in antibiotic resistance but not a parallel increase in new agents with significantly improved spectrum of activity. Without concerted action from the pharmaceutical industry, physicians, academia, health care providers, and governments, the prospects look gloomy.
Bax
R P
RP
Department of Clinical Research and Development, SmithKline Beecham Pharmaceuticals, Harlow, Essex, England.
D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D004345:Drug Industry / Q000639:trends*; D004352:Drug Resistance, Microbial; D005544:Forecasting; D014943:Global Health; D010601:Pharmacology, Clinical / Q000639:trends*
D000900:Anti-Bacterial Agents